Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review
{{output}}
Several genetic disruptions lead to constitutive activation of those kinases leukemic cells depend on for survival and proliferation. Kinase inhibitors (KI) are major therapeutic innovations for chronic myeloid leukemia (CML), chronic lymphoid leukemia (CLL) a... ...
